With 6-figure Dr. Oz Investment, iBeat Launches Heart-monitoring Watch

“Sudden death doesn’t sneak up on you; it smacks you in the face,” said Oz during a press conference for the launch. “The survival rate for out-of-hospital cardiac arrest is 5 percent. People can’t respond fast enough. This technology will help us protect people from that.”
Oz, who has signed on as a special advisor to iBeat and also invested a six-figure amount in the company, said he was drawn into the product because it offered something others were not, namely technology that is continuously monitoring function rather than a button people press in the event of a major event.
“What attracted me was, people who have sudden cardiac arrest don’t have the ability to even push a button. They just go down. So this is different in that it’s a step up from what’s currently out there,” said Oz.
The device launched on Indiegogo for $99 with a 12-month free monitoring service, but after that, it will cost $200 per year. It is battery-powered, cellular-enabled and has built-in GPS, to make it easier for less tech-savvy consumers to immediately start using it, and it does not require a smartphone app.
Howard, iBeat's CEO, explained that the company is looking to offer more in the future. Currently, it only passively monitors biometrics and notices when heart function drops of dramatically, or stops. Since patient data is continuously stored and aggregated, iBeat hopes to soon have the ability to offer predictive analytics, knowing in advance when a heart attack or stroke is coming and alerting all necessary parties as quickly as possible.
“We want to get to the point where we can see the early parameters leading up to a heart attack or stroke moments or hours before,” Howard said.
To enable that potential service, Howard told MobiHealthNews the company will be looking into FDA clearance in the next year.
“Right now, we’re not at a place where we are saying, ‘you are going through cardiac arrest,’ but alerting people and staying with you as a dispatch once you go outside healthy parameters,” he said. Oz, who is a heart surgeon, also said this version of the iBeat Life Monitor is a precursor for more to come.
“We lose a million people a year to sudden death, but, of course the numbers don’t describe the pain of folks dying in front of loved ones or by themselves, which is how it often happens,” he said. “We’re optimistic we can move the needle on that, and this watch will become the tip of iceberg in this endeavor because there are a lot of things that can come from it.” (By Heather Mack, http://www.mobihealthnews.com)
Oz, who has signed on as a special advisor to iBeat and also invested a six-figure amount in the company, said he was drawn into the product because it offered something others were not, namely technology that is continuously monitoring function rather than a button people press in the event of a major event.
“What attracted me was, people who have sudden cardiac arrest don’t have the ability to even push a button. They just go down. So this is different in that it’s a step up from what’s currently out there,” said Oz.
The device launched on Indiegogo for $99 with a 12-month free monitoring service, but after that, it will cost $200 per year. It is battery-powered, cellular-enabled and has built-in GPS, to make it easier for less tech-savvy consumers to immediately start using it, and it does not require a smartphone app.
Howard, iBeat's CEO, explained that the company is looking to offer more in the future. Currently, it only passively monitors biometrics and notices when heart function drops of dramatically, or stops. Since patient data is continuously stored and aggregated, iBeat hopes to soon have the ability to offer predictive analytics, knowing in advance when a heart attack or stroke is coming and alerting all necessary parties as quickly as possible.
“We want to get to the point where we can see the early parameters leading up to a heart attack or stroke moments or hours before,” Howard said.
To enable that potential service, Howard told MobiHealthNews the company will be looking into FDA clearance in the next year.
“Right now, we’re not at a place where we are saying, ‘you are going through cardiac arrest,’ but alerting people and staying with you as a dispatch once you go outside healthy parameters,” he said. Oz, who is a heart surgeon, also said this version of the iBeat Life Monitor is a precursor for more to come.
“We lose a million people a year to sudden death, but, of course the numbers don’t describe the pain of folks dying in front of loved ones or by themselves, which is how it often happens,” he said. “We’re optimistic we can move the needle on that, and this watch will become the tip of iceberg in this endeavor because there are a lot of things that can come from it.” (By Heather Mack, http://www.mobihealthnews.com)
Last modified onSaturday, 06 May 2017 10:07
Latest from Admin TOA
- Hiram & Solomon Cigars Introduces the Patriot Cigar Honoring M.W. George F. Hamilton, 91st Grand Master of Masons in Massachusetts
- PCA Officially Announces 2025 Trade Show Dates
- Galaxy Group Gets DO&CO Detroit Project
- Necla Ozkan Joins Coldwell Banker Realty’s 2024 Sterling Society for Outstanding Sales Performance
- "Discovering Hidden Gems: Inspiring Stories from New York Life & Beyond"